اثربخشی طرح‌وارۀ درمانی هیجانی بر شدت و فراوانی علائم جسمی و کیفیت‌ زندگی بیماران مبتلا به سندرم رودۀ تحریک‌پذیر

Lacy BE, Chey WD, Lembo AJ. New and Emerging Treatment Options for Irritable Bowel Syndrome. Gastroenterol Hepatol NY 2015; 11(4): 1-19. Oerlemans S, van Cranenburgh O, Herremans PJ, Spreeuwenberg P, van Dulmen S. Intervening on cognitions and behavior in irritable bowel syndrome: a feasibility trial using PDAs. Journal Psychosomatic Research 2011; 70(3): 267-77. Eriksson EM, Andrén KI, Kurlberg GK, Eriksson HT. Aspects of the non-pharmacological treatment of irritable bowel syndrome. World Journal of Gastroenterology 2015; 21(40): 11439-49. Brun-Strang C, Dapoigny M, Lafuma A, Wainsten JP, Fagnani F. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study. European Journal of Gastroenterology & Hepatology 2007; 19(12): 1097-103. Michalsen VL, Vandvik PO, Farup PG. Predictors of health-related quality of life in patients with irritable bowel syndrome. A cross-sectional study in Norway. Health and Quality of Life Outcomes 2015; 13: 113. Stanculete MF, Matu S, Pojoga C, Dumitrascu DL. Coping strategies and irrational beliefs as mediators of the health-related quality of life impairments in irritable bowel syndrome. Journal of Gastrointestinal and Liver Diseases 2015; 24(2): 159-64. Zhu L, Huang D, Shi L, Liang L, Xu T, Chang M, et al. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea. Health and Quality of Life Outcomes 2015; 13: 49. Coffin B, Dapoigny M, Cloarec D, Comet D, Dyard F. Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroentérologie Clinique et Biologique 2004; 28(1): 11-15. De Gucht V. Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patients. Quality of Life Research 2015; 24(8): 1845-56. Masaeli N, Kheirabadi GhR, Afshar H, Merasi MR, Daghaghzadeh H, Rohafza HR. Relationship between quality of life and symptom severity in patients with irritable bowel syndrome. The Journal of Behavioral Health Services & Research 2013; 11(1): 39-45. Canavan C, West J, Card T. Change in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort Study. PLoS One 2015; 10(10). Ferreira NB, Eugenicos M, Morris PG, Gillanders D. Using Acceptance and Commitment Therapy to understand and improve outcomes in Irritable Bowel Syndrome. Gastrointestinal Nursing 2011; 9(9): 30-36. Naliboff BD, Frese MP, Rapgay L. Mind/Body psychological treatments for irritable bowel syndrome. Evidence-Based Complementary and Alternative Medicine 2008; 5(1): 41–50. Ballou S, Bedell A, Keefer L. Psychosocial impact of irritable bowel syndrome: A brief review. World Journal of Gastrointestinal Pathophysiology 2015; 6(4): 120-23. Lackner JM, Gudleski GD, Ma CX, Dewanwala A, Naliboff B. Representing the IBSOS Outcome Study Research Group. Fear of GI symptoms has an important impact on quality of life in patients with moderate-to-severe IBS. American Journal of Gastroenterology 2014; 109(11): 1815-23. Sarafino E P. Health psychology. Translated by: Mirzaie at el. Tehran: Roshd, 2008. Altayar O, Sharma V, Prokop LJ, Sood A, Murad MH. Psychological therapies in patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Gastroenterology Research and Practice 2015. Fjorback LO. Mindfulness and bodily distress. Danish Medical Journal 2012; 59(11). Prasko J, Jelenova D, Mihal V. Psychological aspects and psychotherapy of inflammatory bowel diseases and irritable bowel syndrome inchildren. Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia 2010; 154(4): 307-14. Gerson CD, Gerson J, Gerson MJ. Group hypnotherapy for irritable bowel syndrome with long-term follow-up. International Journal of Clinical and Experimental Hypnosis 2013; 61(1): 38-54. Smith GD. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome. Journal of Clinical Nursing 2006; 15(6): 678-84. Moser G, Trägner S, Gajowniczek EE, Mikulits A, Michalski M, Kazemi-Shirazi L, et al. Long-term success of gut-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. American Journal of Gastroenterology 2013; 108(4): 602-9. Jang AL, Hwang SK, Kim DU. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: a randomized trial. European Journal of Gastroenterology & Hepatology 2014; 26(8): 918-26. Ebrahimi A, Naddafnia L, Neshatdust HT, Talebi H, Afshar H, Daghaghzadeh H, et al. The Effectiveness of Cognitive Behavioral Therapy on Symptoms Intensity, Quality of Life, and Mental Health in Patients with Irritable Bowel Syndrome. International journal of body, mind and culture 2015; 2(2). Li L, Xiong L, Zhang S, Yu Q, Chen M. Cognitive-behavioral therapy for irritable bowel syndrome: a meta-analysis. Journal of Psychosomatic Research 2014; 77(1): 1-12. Ae Lee J, Sun-Kyung H, Dong UK K. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: a randomized trial. European Journal of Gastroenterology & Hepatology 2014; 26(8): 918-26. Herbert JD, Forman EM. Emotional schema therapy: A bridge over troubled waters. In: Leahy RL. Acceptance and mindfulness in cognitive behavior therapy: understanding and applying the new therapies 2012. Leahy RL, Tirch D, Napolitano LA. Emotion regulation in psychotherapy: a practitioner's guide. Translated by: Mansouri Rad. Tehran: Arjmand 2014. Halpert A, Rybin D, Dorso G. Expressive writing is a promising therapeutic modality for the management of IBS: A pilot study. American Journal of Gastroenterology 2010; 105(11): 2440-48. Kheir-Abadi GhR, Bagherian R, Nemati K, Daghaghzadeh H, Maracy MR, Gholamrezaei A. The effectiveness of coping strategies training on symptom severity, quality of life and psychological symptoms among patients with irritable bowel syndrome. Journal of Isfahan Medical School 2010; 28(110): 473-83. Henrich JF, Knittle K, De Gucht V, Warren S, Dombrowski SU, Maes S. Identifying effective techniques within psychological treatments for irritable bowel syndrome: a meta-analysis. Journal of Psychosomatic Research 2015; 78(3): 205-22. van der Veek PP, van Rood YR, Masclee AA. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2007; 26(6): 943-52. Ljótsson B, Andréewitch S, Hedman E, Rück C, Andersson G, Lindefors N. Exposure and mindfulness based therapy for irritable bowel syndrome an open pilot study. Journal of Behavior Therapy and Experimental Psychiatry 2010; 41(3): 185-90. Zomorodi S, Rasoulzadeh Tabatabaei SK, Arbabi M, Ebrahimi Daryani N, Azad Fallah P. Comparison of the effectiveness of cognitive-behavior therapy and mindfulness based therapy on the decrease in symptoms of patients who suffer from irritable bowel syndrome.Govaresh 2013; 18(2): 88-94. Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. The American Journal of Gastroenterology 2011; 106: 1678-88. Garland EL, Gaylord SA, Palsson O, Faurot K, Mann JD, Whitehead WE. Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. Journal of Behavioral Medicine 2012; 35(6): 591-602. Lakhan SE, Schofield KL. Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta-analysis. PLoS One 2013; 8(8). Aucoin M, Lalonde-Parsi MJ, Cooley K. Mindfulness-based therapies in the treatment of functional gastrointestinal disorders: a meta-analysis. Evidence-Based Complementary and Alternative Medicine 2014. Safaee A,Khoshkrood-Mansoori B, Pourhoseingholi M A, Moghimi-Dehkord B, Pourhoseingholi A, Habibi M, et al. Prevalence of irritable bowel syndrome: a population based study. Urmia Medical Journal 2013; 24(1):17-23. Sharifi V, Asadi SM, MOhammadi MR, Amini H, Kaviyani H, Semnani Y, et al. The reliability and applicability of the Persian version structured clinical interview for DSM-IV(SCID). Advances in Cognitive Science 2005; 6(1&2): 10-22. Solati Dehkordy K, Adibi P, Ghamarani A. The Effects of Cognitive – Behavior Therapy and Drug Therapy on Quality of Life and Symptoms. Journal of Kerman University of Medical Sciences 2012; 19(1): 94-103. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Digestive Diseases and Sciences 1998; 43(2): 400-11. Haghayegh SA, Neshatdoost H, Drossman DA, Asgari K, Soulati SK, Adibi P. Psychometric Characteristics of the Persian Version of the Irritable Bowel Syndrome Quality of Life Questionnaire (P-IBS-QOL). Pakistan Journal of Medical Sciences 2012; 28(2): 312-17 Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991; 59(1): 9-12. Izadi R, Abedi MR. Acceptance & Commitment Therapy. Tehran: Jungle 2014. Bowers H, Wroe A. Beliefs about emotions mediate the relationship between emotional suppression and quality of life in irritablebowel syndrome. Journal of Mental Health. 2015; 3: 1-5. Alipour A, Noorbala AA. Fundementals of psychoneuroimmunology. Tehran: Medical sciences 2004. Zargar F. Acceptance-based behaviour therapies. The introduction of the third generation cognitive-behavioral therapies. Tehran: Arjmand 2015.